Companies: 10,795·Total market cap: $144.5T
Haemonetics Corporation

Haemonetics Corporation

HAENYSEHealthcare● Active
$72.99
+$1.71(+2.40%)
Market Cap$3.3B
P/E Ratio
52W High$87.32
52W Low$47.32

Haemonetics Corporation(HAE)· 损益表

年度 / 季度 / TTM 视图 · SEC 10-K 与 10-Q(经 FMP 聚合)· 可在下方切换周期与 M/B/T 单位。

FMP · HAE · 截至 2026-06-08

财务报表

Revenue · Gross Profit · Net Income
Breakdown2026-032025-032024-032023-032022-03
Revenue
Revenue$1.33B$1.36B$1.31B$1.17B$0.99B
Cost of Revenue$0.59B$0.58B$0.60B$0.55B$0.46B
Gross Profit$0.74B$0.78B$0.71B$0.62B$0.53B
Gross Margin %(computed)55.74%57.21%54.38%53.30%53.44%
Operating Expenses
R&D Expenses$0.06B$0.07B$0.06B$0.06B$0.06B
G&A Expenses$0.00B$0.41B$0.41B$0.37B$0.33B
Total Operating Expenses$0.50B$0.56B$0.55B$0.47B$0.45B
Operating Income$0.24B$0.22B$0.16B$0.16B$0.08B
Operating Margin %(computed)18.10%16.30%12.60%13.35%8.13%
Interest Income$0.00B$0.00B$0.00B$0.00B$0.00B
Interest Expense$0.03B$0.01B$0.01B$0.01B$0.02B
Income Before Tax$0.13B$0.21B$0.15B$0.14B$0.06B
Income Tax Expense$0.03B$0.04B$0.03B$0.03B$0.02B
Net Income$0.10B$0.17B$0.12B$0.12B$0.04B
Net Margin %(computed)7.29%12.32%8.98%9.87%4.37%
Per Share & EBITDA
EPS (Basic)$2.05$3.31$2.32$2.27$0.85
Wtd Avg Shares0.05B0.05B0.05B0.05B0.05B
EBITDA$0.40B$0.36B$0.30B$0.25B$0.19B
EBITDA Margin %(computed)29.77%26.16%22.57%21.56%19.30%

数据来源:Financial Modeling Prep · 最后更新:2026-06-08 · USD · B

深入了解Haemonetics Corporation

关于Haemonetics Corporation(HAE)损益表

Haemonetics Corporation(HAE)损益表数据来源于SEC Form 10-K及10-Q申报文件。2026财年,HAE实现营收$1.33B,毛利润$0.74B(毛利率55.74%),净利润$0.10B(净利率7.29%)。

常见问题

HAE · 4 问

Haemonetics Corporation(HAE)2026财年营收为$1.33B,同比down2.0%。

HAE revenueHAE salesannual revenue YoYincome statement

· Source: FMP /stable/income-statement · SEC EDGAR Form 10-K & 10-Q · As of 2026-06-08